HB Wealth Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$169K Buy
12,416
+832
+7% +$11K ﹤0.01% 1753
2026
Q2
$109K Buy
11,584
+78
+0.7% +$745 ﹤0.01% 1655
2026
Q1
$105K Buy
11,506
+464
+4% +$3.89K ﹤0.01% 1494
2025
Q4
$82.2K Buy
11,042
+205
+2% +$1.47K ﹤0.01% 1370
2025
Q3
$72.5K Buy
+10,837
New +$75.2K ﹤0.01% 1315
2025
Q2
– Sell
-10,504
Closed -$96.1K – 1184
2025
Q1
$96.1K Hold
10,504
– – ﹤0.01% 1176
2024
Q4
$110K Hold
10,504
– – ﹤0.01% 1022
2024
Q3
$126K Hold
10,504
– – ﹤0.01% 917
2024
Q2
$60.4K Buy
+10,504
New +$57.6K ﹤0.01% 895

Other funds holding BVS

HB Wealth Management's BVS Position: Q3 2026 in Review

HB Wealth Management increased its Bioventus (BVS) stake by 7.2% in Q3 2026, buying an estimated $11K and bringing the position to 12,416 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

HB Wealth Management first reported a position in BVS in Q2 2024 and has held it in 9 quarters since. 23 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

  • HB Wealth Management held 12,416 shares of Bioventus worth $169K as of Q3 2026.
  • HB Wealth Management bought 832 Bioventus shares in Q3 2026, an estimated $11K.
  • Bioventus made up ﹤0.01% of HB Wealth Management's portfolio in Q3 2026, its #1753 holding.
  • HB Wealth Management first reported a position in Bioventus in Q2 2024 and has held it in 9 quarters since.
  • 23 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on HB Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.